prostate tumor
Conditions
Interventions
Gold Standard:Pathologic analysis of punctured biopsy
PET/CT-guided 
the 
of 
prostate
Sponsors
The First Affiliated Hospital of Fujian Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with negative random prostate biopsy under the guidance of previous transrectal ultrasound and continuous elevation of serum PSA (4ng/ml<=PSA<10ng/ml); 2. ECOG performance status score 0-2; 3. Main organ function: no obvious abnormality in liver, kidney, bone marrow, heart and other important organ functions; 4. There is no obvious abnormality in the electrocardiogram, or the abnormality has no clinical significance; 5. All enrolled subjects should take adequate barrier contraceptive measures throughout the treatment period and within 4 weeks after the end of treatment; 6. Patients must have the ability to understand and voluntarily sign the informed consent form, which must be signed prior to any trial process; 7. No other malignant tumor other than prostate cancer at the time of initial diagnosis; 8. Patients who have not received endocrine, surgery or radiotherapy and chemotherapy before.
Exclusion criteria
Exclusion criteria: 1. Abnormal blood coagulation mechanism; 2. Patients with acute urinary tract infection; 3. Those who are contraindicated in CT examination; 4. Incomplete collection of data and information; 5. Patients with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related diseases or infections; 6. Patients who abuse alcohol or narcotic drugs, have a history of drug abuse, or have a history of mental illness; 7. Patients who cannot cooperate with the relevant examinations of this project and do not agree to sign the informed consent; 8. Patients with claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological type of tumor;Age;Body Mass Index;Maximal standard uptake value;Mean standard uptake value;Number of positive needles;Proportion of tumor;Gleason score;Prostate specific antigen; | — |
Countries
China
Contacts
Public ContactXu Ning
The First Affiliated Hospital of Fujian Medical University
Outcome results
None listed